Information Statement

The American Academy of Ophthalmology recognizes that screening for diabetic retinopathy using validated digital imaging can be a sensitive and effective detection method. Such technology has not been demonstrated to be as effective, however, at detecting and quantifying the spectrum of other ophthalmic pathology that can accompany diabetic retinopathy, including cataract and glaucoma, which are more prevalent in patients with diabetes mellitus. Imaging technology also does not mitigate the need for periodic comprehensive ophthalmic examinations.